Oscar Health (NYSE:OSCR) Director Mario Schlosser Sells 600,000 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 600,000 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00. Following the completion of the transaction, the director directly owned 480,866 shares of the company’s stock, valued at $14,589,474.44. This trade represents a 55.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The shares were sold at an average price of $30.79, for a total value of $4,618,500.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $748,592.80.

Oscar Health Price Performance

Shares of OSCR opened at $30.00 on Tuesday. The firm has a market capitalization of $9.26 billion, a price-to-earnings ratio of 21.43, a price-to-earnings-growth ratio of 0.63 and a beta of 2.36. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $33.55. The stock’s fifty day moving average is $30.30 and its 200-day moving average is $22.25.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% on a year-over-year basis. During the same period in the previous year, the business earned ($0.89) earnings per share. Equities analysts anticipate that Oscar Health, Inc. will post 1.54 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Robert W. Baird set a $27.00 price objective on shares of Oscar Health in a research note on Friday, August 7th. Barclays boosted their target price on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Wells Fargo & Company upped their target price on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.22.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in shares of Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after buying an additional 116,430 shares in the last quarter. BIT Capital GmbH grew its position in Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after buying an additional 5,227,152 shares during the last quarter. Simplify Asset Management Inc. acquired a new position in Oscar Health in the fourth quarter worth approximately $2,948,000. Finally, Fortis Group Advisors LLC increased its holdings in shares of Oscar Health by 82.9% in the fourth quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock valued at $2,724,000 after buying an additional 86,035 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.